Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
-
WiSe 2025
Vergangene Veranstaltungen (max. 10)
-
SoSe 2025
- Seminar für Molekularbiologie / Zellbiologie u. experimentelle Krebsforschung (mit Gastsprechern) (*)
- Praktikum Zell- und Molekularbiologie für med. Biologen (Bachelor) (PV)
- Prinzipien der zellulären Signaltransduktion (*)
- Molekulare Mechanismen bakterieller Infektionen (*)
- Molekulare Immunologie (*)
- Anleitung zu selbständigem wissenschaftlichen Arbeiten (*)
-
WiSe 2024
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Amitriptyline potently neutralizes distinct SARS-CoV-2 variants including D614G, Omicron BA.5, and Omicron XBB.1In: Frontiers in Microbiology, Jg. 16, 2025, 1631947DOI, Online Volltext (Open Access)
-
Caveolin-1 affects early mycobacterial infection and apoptosis in macrophages and miceIn: Tuberculosis, Jg. 147, 2024, 102493DOI (Open Access)
-
Fluoxetine and Sertraline Potently Neutralize the Replication of Distinct SARS-CoV-2 VariantsIn: Viruses, Jg. 16, 2024, Nr. 4, 545DOI (Open Access)
-
Sphingosine kills intracellular Pseudomonas aeruginosa and Staphylococcus aureusIn: Pathogens and Disease, Jg. 82, 2024, ftae016DOI (Open Access)
-
Simultaneous targeting of mitochondrial Kv1.3 and lysosomal acid sphingomyelinase amplifies killing of pancreatic ductal adenocarcinoma cells in vitro and in vivoIn: Journal of Molecular Medicine, Jg. 101, 2023, Nr. 3, S. 295 – 310DOI (Open Access)
-
Mitochondrial Kv1.3 Channels as Target for Treatment of Multiple MyelomaIn: Cancers, Jg. 14, 2022, Nr. 8, 1955DOI, Online Volltext (Open Access)
-
Sphingosine as a new antifungal agent against Candida and Aspergillus spp.In: International Journal of Molecular Sciences (IJMS), Jg. 23, 2022, Nr. 24, 15510DOI, Online Volltext (Open Access)
-
Corrigendum to: “Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the family”In: Redox Biology, Jg. 45, 2021, 102036DOI (Open Access)
-
Characterization of the small molecule ARC39, a direct and specific inhibitor of acid sphingomyelinase in vitroIn: Journal of Lipid Research, Jg. 61, 2020, Nr. 6, S. 896 – 910DOI (Open Access)
-
Insight into the mechanism of cytotoxicity of membrane-permeant psoralenic Kv1.3 channel inhibitors by chemical dissection of a novel member of the familyIn: Redox Biology, Jg. 37, 2020, 101705DOI (Open Access)
-
Acid sphingomyelinase deficiency ameliorates farber diseaseIn: International Journal of Molecular Sciences (IJMS), Jg. 20, 2019, Nr. 24, S. 6253DOI (Open Access)
-
Pathological manifestations of Farber disease in a new mouse modelIn: Biological Chemistry, Jg. 399, 2018, Nr. 10, S. 1183 – 1202DOI, Online Volltext (Open Access)
-
Targeting the potassium channel Kv1.3 kills glioblastoma cellsIn: Neurosignals, Jg. 25, 2018, Nr. 1, S. 26 – 38DOI (Open Access)
-
Direct pharmacological targeting of a mitochondrial ion channel selectively kills tumor cells in vivoIn: Cancer Cell, Jg. 31, 2017, Nr. 4, S. 516 – 531.e10DOI (Open Access)
-
Acid sphingomyelinase inhibition protects mice from lung edema and lethal Staphylococcus aureus sepsisIn: Journal of Molecular Medicine, Jg. 93, 2015, Nr. 6, S. 675 – 689DOI (Open Access)
-
Impaired glucose and lipid metabolism in ageing aryl hydrocarbon receptor deficient miceIn: EXCLI Journal, Jg. 14, 2015, S. 1153 – 1163
-
Targeting a mitochondrial potassium channel to fight cancerIn: Cell Calcium, Jg. 58, 2015, Nr. 1, S. 131 – 138